Strybol Kaat Pharma SRL
Strybol Kaat Pharma reported total assets of 749,285 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
By total assets for 2025, Strybol Kaat Pharma ranks among the 2,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Strybol Kaat Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +189 % Total assets +1247 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Strybol Kaat Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Strybol Kaat Pharma's financial analysis
- Solvency10.9%sector median: 54.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Strybol Kaat Pharma
Strybol Kaat Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0695.461.591
- VAT number
- BE0695461591
- Peppol
- Registered · 0208:0695461591 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Apr 2018
- Registered office
- 3040 Huldenberg
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Strybol Kaat Pharma (SRL) has been based in Huldenberg since 2018, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 35,060 € and equity of 81,572 €; its revenue is not published. Its solvency stands at 10.9%, below the median of its sector (54.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Strybol Kaat Pharma
Companies in the same business, of comparable size and area, outside its group.
- Adamanthea Other business support service activities n.e.c. Antwerp · balance sheet 962,179 €
- Alphar Moignelee Other business support service activities n.e.c. Sambreville · balance sheet 717,314 €
- Selusi Other business support service activities n.e.c. Herselt · balance sheet 793,685 €
- Amrezi Other business support service activities n.e.c. Grimbergen · balance sheet 670,734 €
- RA Consulting Other business support service activities n.e.c. Genk · balance sheet 842,506 €
- Armanco Other business support service activities n.e.c. Nazareth-De Pinte · balance sheet 659,542 €
- Codecon Other business support service activities n.e.c. Lochristi · balance sheet 651,841 €
- Filip Spans Other business support service activities n.e.c. Aartselaar · balance sheet 881,129 €
Frequently asked questions about Strybol Kaat Pharma
What is the revenue of Strybol Kaat Pharma?
Strybol Kaat Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Strybol Kaat Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0695461591 for Strybol Kaat Pharma, if the company is VAT-registered. Its company number (CBE) is 0695.461.591.
Where is the registered office of Strybol Kaat Pharma?
According to the CBE register, the registered office of Strybol Kaat Pharma is in 3040 Huldenberg.
What is the equity of Strybol Kaat Pharma?
At the close of the 2025 financial year, the equity of Strybol Kaat Pharma amounts to 81,572 €, a solvency of 10.9% of total assets.
Who manages Strybol Kaat Pharma?
The register lists 1 active mandates at Strybol Kaat Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Strybol Kaat Pharma within its sector?
By total assets for 2025, Strybol Kaat Pharma ranks among the 2,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of Strybol Kaat Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →